hospitalisations by death might have. , ., , ., have. the news of the efficacy of this particular — have. the news of the efficacy of this particular antiviral _ have. the news of the efficacy of this particular antiviral is - this particular antiviral is obviously particularly good news was at the company, when they briefed us last night had they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated elderly or medically at risk volunteers within five days of them showing corona virus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised compared to 14.1% those who did not take tablets. eight patients were given a placebo later dies of covert but there were no deaths in the group taking the pill. the trial was stopped early because the pill was so successful. the data still needs to be peer—reviewed. so how does it work? as coronavirus replicates itself inside your body these antiviral pills tricked into using the drug which then inserts